文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

斯威士兰接受抗逆转录病毒治疗的青少年病毒载量抑制的决定因素:一项横断面研究。

Determinants of viral load suppression among adolescents on antiretroviral therapy in Eswatini: a cross-sectional study.

作者信息

Hlophe Londiwe D, Shumba Constance S, Bedada Diribsa T, Nyasulu Peter S

机构信息

Division of Epidemiology and Biostatistics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Division of Epidemiology and Social Sciences, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, United States of America.

出版信息

BMC Infect Dis. 2025 Apr 10;25(1):493. doi: 10.1186/s12879-025-10872-z.


DOI:10.1186/s12879-025-10872-z
PMID:40205329
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11983843/
Abstract

BACKGROUND: The goal of antiretroviral therapy (ART) is to achieve a sustained HIV suppressed viral load. However, adolescents often present poor adherence to ART which is associated with lower rates of viral load suppression (VLS). The objective of this study was to determine the viral load suppression levels and the associated factors among adolescents living with HIV (ALHIV) and on ART in Eswatini. METHODS: We conducted cross-sectional analysis of data from 911 adolescents aged 10 to 19 living with HIV and on ART between the period January 2017 and September 2022. We collected data of demographic and clinical variables, using a standardized data abstraction tool. We defined viral load suppression as the latest viral load result of ≤ 1000 copies/ml. Univariable and bivariable logistic regression analysis was done to identify factors associated with VLS and factors with p < 0.1 were included in the multivariable regression analysis to adjust for the confounding effect of other variables such as age, sex, and duration of ART. Factors with p < 0.05 were considered statistically significant. RESULTS: Among the 911 participants, 60% (457) were female. The mean age of the participants was 16.3 years, with mean duration on ART of 1.8 years. Viral suppression was attained by 88.5% (806/911) of the participants. Residence in the Shiselweni region was an independent factor associated with viral load suppression (aOR 0.37; 95% CI 0.15-0.19; p˂0.027). CONCLUSION: Low VLS is a risk factor for increased viral resistance and perpetuates HIV transmission within the population. Achieving viral suppression among ALHIV in Eswatini is challenging as data shows that VLS is way below the UNAIDS 95% cut off level among individuals on ART. This is particularly more problematic in the Shiselweni region, where viral suppression is lower than the other regions. Therefore, reinforcement of public health interventions is needed to improve treatment support for achieving sustained viral suppression among ALHIV in Eswatini.

摘要

背景:抗逆转录病毒疗法(ART)的目标是实现持续的HIV病毒载量抑制。然而,青少年对抗逆转录病毒疗法的依从性往往较差,这与较低的病毒载量抑制率(VLS)相关。本研究的目的是确定斯威士兰接受抗逆转录病毒治疗的感染HIV青少年(ALHIV)的病毒载量抑制水平及其相关因素。 方法:我们对2017年1月至2022年9月期间911名年龄在10至19岁之间接受抗逆转录病毒治疗的感染HIV青少年的数据进行了横断面分析。我们使用标准化的数据提取工具收集了人口统计学和临床变量数据。我们将病毒载量抑制定义为最新病毒载量结果≤1000拷贝/毫升。进行单变量和双变量逻辑回归分析以确定与病毒载量抑制相关的因素,p<0.1的因素纳入多变量回归分析以调整年龄、性别和抗逆转录病毒治疗持续时间等其他变量的混杂效应。p<0.05的因素被认为具有统计学意义。 结果:在911名参与者中,60%(457名)为女性。参与者的平均年龄为16.3岁,抗逆转录病毒治疗的平均持续时间为1.8年。88.5%(806/911)的参与者实现了病毒抑制。居住在希塞尔韦尼地区是与病毒载量抑制相关的独立因素(调整后的比值比0.37;95%置信区间0.15-0.19;p<0.027)。 结论:低病毒载量抑制是病毒耐药性增加的危险因素,并使HIV在人群中持续传播。在斯威士兰实现感染HIV青少年的病毒抑制具有挑战性,因为数据显示,在接受抗逆转录病毒治疗的个体中,病毒载量抑制远低于联合国艾滋病规划署设定的95%的临界水平。这在希塞尔韦尼地区尤为突出,该地区的病毒抑制率低于其他地区。因此,需要加强公共卫生干预措施,以改善治疗支持,从而在斯威士兰实现感染HIV青少年的持续病毒抑制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/11983843/d9946f2c8d47/12879_2025_10872_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/11983843/d9946f2c8d47/12879_2025_10872_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc4b/11983843/d9946f2c8d47/12879_2025_10872_Fig1_HTML.jpg

相似文献

[1]
Determinants of viral load suppression among adolescents on antiretroviral therapy in Eswatini: a cross-sectional study.

BMC Infect Dis. 2025-4-10

[2]
Prevalence of nonsuppressed viral load and associated factors among HIV-positive adults receiving antiretroviral therapy in Eswatini, Lesotho, Malawi, Zambia and Zimbabwe (2015 to 2017): results from population-based nationally representative surveys.

J Int AIDS Soc. 2020-11

[3]
Barriers to viral load suppression among adolescents living with HIV on anti-retroviral therapy: a retrospective study in Tanga, Tanzania.

AIDS Res Ther. 2024-5-22

[4]
Determinants of viral suppression among adolescents on antiretroviral treatment in Ehlanzeni district, South Africa: a cross-sectional analysis.

AIDS Res Ther. 2021-10-9

[5]
"She tells me the HIV is eating my brains": barriers and facilitators to antiretroviral therapy adherence among Eswatini adolescents living with HIV.

AIDS Care. 2025-2

[6]
Viral suppression among adolescents on HIV treatment in the Sedibeng District, Gauteng province.

Curationis. 2022-9-27

[7]
Barriers and facilitators to HIV viral load suppression among adolescents living with HIV in Lubumbashi, Democratic Republic of the Congo: A qualitative study.

PLoS One. 2025-3-25

[8]
Viral suppression among pregnant adolescents and women living with HIV in rural KwaZulu-Natal, South Africa: a cross sectional study to assess progress towards UNAIDS indicators and Implications for HIV Epidemic Control.

Reprod Health. 2022-5-12

[9]
Examining teen club attendance and viral load suppression among adolescents under differentiated HIV care in Malawi: a sub-optimal scenario.

BMC Public Health. 2024-12-30

[10]
Factors associated with viral non-suppression among adolescents living with HIV in Cambodia: a cross-sectional study.

AIDS Res Ther. 2018-11-17

引用本文的文献

[1]
A self-disclosure model for adolescents with perinatally acquired HIV in Eswatini.

Curationis. 2025-7-31

本文引用的文献

[1]
Barriers and facilitators to anti-retroviral therapy adherence among adolescents aged 10 to 19 years living with HIV in sub-Saharan Africa: A mixed-methods systematic review and meta-analysis.

PLoS One. 2023

[2]
Impact of COVID-19 on HIV Adolescent Programming in 16 Countries With USAID-Supported PEPFAR Programs.

J Acquir Immune Defic Syndr. 2023-8-1

[3]
Determinants and rates of retention in HIV care among adolescents receiving antiretroviral therapy in Windhoek, Namibia: a baseline cohort analysis.

BMC Public Health. 2023-3-8

[4]
Impact of COVID-19 on Adolescent HIV Prevention and Treatment Services in the AHISA Network.

AIDS Behav. 2023-5

[5]
Impact of COVID-19 on Adolescent HIV Prevention and Treatment Research in the AHISA Network.

AIDS Behav. 2023-5

[6]
Adherence challenges and opportunities for optimizing care through enhanced adherence counseling for adolescents with suspected HIV treatment failure in Kenya.

BMC Health Serv Res. 2022-7-29

[7]
Accuracy of measures for antiretroviral adherence in people living with HIV.

Cochrane Database Syst Rev. 2022-7-25

[8]
HIV suppression was maintained during the COVID-19 pandemic in Malawi: a program-level cohort study.

J Clin Epidemiol. 2022-10

[9]
"I have never talked to anyone to free my mind" - challenges surrounding status disclosure to adolescents contribute to their disengagement from HIV care: a qualitative study in western Kenya.

BMC Public Health. 2022-6-4

[10]
Factors associated with HIV viral suppression among children and adults receiving antiretroviral therapy in Malawi in 2021: Evidence from the Laboratory Management Information System.

Trop Med Int Health. 2022-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索